Savara Stock (NASDAQ: SVRA) stock price, news, charts, stock research, profile.
Open | $4.200 |
Close | $4.080 |
Volume / Avg. | 719.046K / 873.157K |
Day Range | 4.075 - 4.270 |
52 Wk Range | 2.460 - 5.700 |
Market Cap | $584.539M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 3.89% |
Days to Cover | 4.27 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Savara (NASDAQ: SVRA) through any online brokerage.
Other companies in Savara’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Altimmune (NASDAQ:ALT), Pharming (NASDAQ:PHAR) and Kyverna Therapeutics (NASDAQ:KYTX).
The latest price target for Savara (NASDAQ: SVRA) was reported by Oppenheimer on Tuesday, May 21, 2024. The analyst firm set a price target for 11.00 expecting SVRA to rise to within 12 months (a possible 160.05% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Savara (NASDAQ: SVRA) is $4.23 last updated May 24, 2024 at 7:33 PM EDT.
There are no upcoming dividends for Savara.
Savara’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Savara.
Savara is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.